Related references
Note: Only part of the references are listed.Investigation of the interactions of HSA and SARS-CoV-2 papain-like protease against eugenol for novel COVID-19 drug discovery: spectroscopic and insilico study
Farheen Naz et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)
High-throughput virtual screening approach of natural compounds as target inhibitors of plasmepsin-II
Fatima En-nahli et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)
In silico protein engineering shows that novel mutations affecting NAD(+) binding sites may improve phosphite dehydrogenase stability and activity
Soukayna Baammi et al.
SCIENTIFIC REPORTS (2023)
Molecular modeling study of pyrrolidine derivatives as novel myeloid cell leukemia-1 inhibitors through combined 3D-QSAR, molecular docking, ADME/Tox and MD simulation techniques
Kamal Tabti et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)
Towards designing of a potential new HIV-1 protease inhibitor using QSAR study in combination with Molecular docking and Molecular dynamics simulations
Mouna Baassi et al.
PLOS ONE (2023)
An Insightful Evaluation of Evodiamine Analogs Effect as DNA Topoisomerase I Inhibitors Using QSAR Method
Hatim Soufi et al.
Proceedings of the National Academy of Sciences, India. Section B (2023)
The biological activities of butyrylcholinesterase inhibitors
Shiyang Zhou et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
In silico design of novel PIN1 inhibitors by combined of 3D-QSAR, molecular docking, molecular dynamic simulation and ADMET studies
Kamal Tabti et al.
JOURNAL OF MOLECULAR STRUCTURE (2022)
Structural Homology-Based Drug Repurposing Approach for Targeting NSP12 SARS-CoV-2
Abdulelah Aljuaid et al.
MOLECULES (2022)
Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase
Rameez Jabeer Khan et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Multi-Target Drug Candidates for Multifactorial Alzheimer's Disease: AChE and NMDAR as Molecular Targets
Md. Sahab Uddin et al.
MOLECULAR NEUROBIOLOGY (2021)
Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease
Gabriella Marucci et al.
NEUROPHARMACOLOGY (2021)
Exploring indole-based-thiadiazole derivatives as potent acetylcholinesterase and butyrylcholinesterase enzyme inhibitors
Muhammad Taha et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer?s disease
Kamilia M. Amin et al.
BIOORGANIC CHEMISTRY (2021)
Potential therapeutic natural products against Alzheimer's disease with Reference of Acetylcholinesterase
Sagheer Ahmed et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Polypharmacology of Gongronema latifolium leaf secondary metabolites against protein kinases implicated in Parkinson's disease and Alzheimer's disease
Babatunji Emmanuel Oyinloye et al.
SCIENTIFIC AFRICAN (2021)
The State of The Art on Acetylcholinesterase Inhibitors in the Treatment of Alzheimer's Disease
Immacolata Vecchio et al.
JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE (2021)
Exploring the Association Between Sialic Acid and SARS-CoV-2 Spike Protein Through a Molecular Dynamics-Based Approach
Leonardo Bo et al.
FRONTIERS IN MEDICAL TECHNOLOGY (2021)
A QSAR Study for the Prediction of Inhibitory Activity of Coumarin Derivatives for the Treatment of Alzheimer's Disease
Sarah Ghanei-Nasab et al.
ARABIAN JOURNAL FOR SCIENCE AND ENGINEERING (2021)
A review of recent advances towards the development of QSAR models for toxicity assessment of ionic liquids
Natalia Abramenko et al.
JOURNAL OF HAZARDOUS MATERIALS (2020)
Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease
Priya Kashyap et al.
STEROIDS (2020)
Comparative Kinetics of Acetyl- and Butyryl-Cholinesterase Inhibition by Green Tea Catechins|Relevance to the Symptomatic Treatment of Alzheimer's Disease
Edward J. Okello et al.
NUTRIENTS (2020)
Microglia facilitate loss of perineuronal nets in the Alzheimer's disease brain
Joshua D. Crapser et al.
EBIOMEDICINE (2020)
In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer's disease
Vinay Kumar et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2020)
Meta-Analysis of the Alzheimer's Disease Human Brain Transcriptome and Functional Dissection in Mouse Models
Ying-Wooi Wan et al.
CELL REPORTS (2020)
Effective anti-aromatase therapy to battle against estrogen-mediated breast cancer: Comparative SAR/QSAR assessment on steroidal aromatase inhibitors
Nilanjan Adhikari et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Status and Challenges of Density Functional Theory
Pragya Verma et al.
TRENDS IN CHEMISTRY (2020)
Brain Selenium in Alzheimer's Disease (BRAIN SEAD Study): a Systematic Review and Meta-Analysis
Seshadri Reddy Varikasuvu et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2019)
Pharmacophore-based drug design for the identification of novel butyrylcholinesterase inhibitors against Alzheimer's disease
Yingying Jiang et al.
PHYTOMEDICINE (2019)
Expansion of the scaffold diversity for the development of highly selective butyrylcholinesterase (BChE) inhibitors: Discovery of new hits through the pharmacophore model generation, virtual screening and molecular dynamics simulation
Xin Lu et al.
BIOORGANIC CHEMISTRY (2019)
QSAR Classification Models for Predicting the Activity of Inhibitors of Beta-Secretase (BACE1) Associated with Alzheimer's Disease
Ignacio Ponzoni et al.
SCIENTIFIC REPORTS (2019)
Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid
Petros Takousis et al.
ALZHEIMERS & DEMENTIA (2019)
In silico rational design and virtual screening of antixoidant tripeptides based on 3D-QSAR modeling
Haiqiong Guo et al.
JOURNAL OF MOLECULAR STRUCTURE (2019)
Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer's Disease-Could BCHE Genotyping Be Helpful in Alzheimer's Therapy?
Jacek Jasiecki et al.
BIOMOLECULES (2019)
Comparison of the inhibitory potential towards carbonic anhydrase, acetylcholinesterase and butyrylcholinesterase of chalcone and chalcone epoxide
Nashia Stellenboom
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2019)
Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening
Noor Atatreh et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Intriguing role of water in protein-ligand binding studied by neutron crystallography on trypsin complexes
Johannes Schiebel et al.
NATURE COMMUNICATIONS (2018)
Antiplasmodial Activity, Cytotoxicity and Structure-Activity Relationship Study of Cyclopeptide Alkaloids
Emmy Tuenter et al.
MOLECULES (2017)
Insights into Protein-Ligand Interactions: Mechanisms, Models, and Methods
Xing Du et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Molecular docking and simulation studies to give insight of surfactin amyloid interaction for destabilizing Alzheimer's Aβ42 protofibrils
Ashish Verma et al.
MEDICINAL CHEMISTRY RESEARCH (2016)
POINTS OF SIGNIFICANCE Model selection and overfitting
Jake Lever et al.
NATURE METHODS (2016)
Principal component analysis: a review and recent developments
Ian T. Jolliffe et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES (2016)
Discovery, Biological Evaluation, and Crystal Structure of a Novel Nanomolar Selective Butyrylcholinesterase Inhibitor
Boris Brus et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
A review on cholinesterase inhibitors for Alzheimer's disease
Preet Anand et al.
ARCHIVES OF PHARMACAL RESEARCH (2013)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Quantitative structure activity relationship analysis of aminoimidazoles as BACE-I inhibitors
Priti Jain et al.
MEDICINAL CHEMISTRY RESEARCH (2013)
Comparative Studies on Some Metrics for External Validation of QSPR Models
Kunal Roy et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Molecular Nanomedicine Towards Cancer: 111In-Labeled Nanoparticles
Dimitrios Psimadas et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Best Practices for QSAR Model Development, Validation, and Exploitation
Alexander Tropsha
MOLECULAR INFORMATICS (2010)
Potential Glucocorticoid Receptor Ligands with Pulmonary Selectivity Using I-QSAR with the Signature Molecular Descriptor
Joshua D. Jackson et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2008)
Exploring three-dimensional quantitative structural activity relationship (3D-QSAR) analysis of SCH 66336 (Sarasar) analogues of farnesyltransferase inhibitors
Tabish Equbal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
3D-QSAR Studies of Various Diaryl Urea Derivatives of Multi-targeted Receptor Tyrosine Kinase Inhibitors: Molecular Field Analysis Approach
Neha Kansal et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2008)
Conformational diversity of ligands bound to proteins
GR Stockwell et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Practical considerations on the use of predictive models for regulatory purposes
J Tunkel et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2005)
Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships - The report and recommendations of ECVAM Workshop 52
TI Netzeva et al.
ATLA-ALTERNATIVES TO LABORATORY ANIMALS (2005)
Beware of q(2)!
A Golbraikh et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2002)
Share Paper
